Efficacy and Safety of Antibiotic Therapy in Early Cutaneous Lyme Borreliosis | Zendy

Gabriel Torbahn | Zendy; Heidelore Hofmann | Zendy; Gerta Rücker | Zendy; Karin Bischoff | Zendy; M. Freitag | Zendy; Rick Dersch | Zendy; Volker Fingerle | Zendy; Edith Motschall | Zendy; Joerg J Meerpohl | Zendy; Christine Schmucker | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy and Safety of Antibiotic Therapy in Early Cutaneous Lyme Borreliosis

Author(s) -

Gabriel Torbahn,

Heidelore Hofmann,

Gerta Rücker,

Karin Bischoff,

M. Freitag,

Rick Dersch,

Volker Fingerle,

Edith Motschall,

Joerg J Meerpohl,

Christine Schmucker

Publication year - 2018

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2018.3186

Subject(s) - medicine , erythema migrans , azithromycin , adverse effect , cefuroxime , amoxicillin , randomized controlled trial , rash , antibiotics , cochrane library , dermatology , pediatrics , borrelia burgdorferi , lyme borreliosis , immunology , antibody , microbiology and biotechnology , biology

Controversies about the choice of antibiotic agent and treatment modality exist in the management of erythema migrans in early cutaneous Lyme borreliosis (LB).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research